Xanthine oxidase inhibition and heart failure: novel therapeutic strategy for ventricular dysfunction?
Hajjar
Roger J
RJ
Leopold
Jane A
JA
D000493:Allopurinol / Q000627:therapeutic use; D000818:Animals; D002311:Cardiomyopathy, Dilated / Q000188:drug therapy*; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy* / Q000378:metabolism; D051381:Rats; D017382:Reactive Oxygen Species; D018754:Ventricular Dysfunction / Q000188:drug therapy*; D014969:Xanthine Oxidase / Q000037:antagonists & inhibitors* / Q000502:physiology
D004791:Enzyme Inhibitors; D017382:Reactive Oxygen Species; D000493:Allopurinol; D014969:Xanthine Oxidase